← Charoen Pokphand Foods overview

Charoen Pokphand Foods vs Danone SA: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Charoen Pokphand Foods Public Company Limited (CPF.BK)

Q3 2026
▲3▼1

CPF beats Q2, plans Vietnam IPO, but China JV drags

  • Q2 profit beat CPF beat Q2 profit forecasts by 13–20%, helped by strong exports and Vietnam operations. This shows the core business is performing better than expected, which supports the stock price.

    Earnings beat is a direct positive catalyst for the stock.

  • Vietnam IPO plan CPF plans to list its Vietnam unit (CP Vietnam) via IPO, potentially unlocking value. This could give investors a new way to profit from CPF's growth in Vietnam.

    IPO plan is a new strategic move that may boost shareholder value.

  • Weak baht and El Niño lift exports A weak baht (14-month low) and El Niño-driven meat supply tightening should lift export earnings and prices. Q3 profit is expected to recover, giving a near-term boost.

    Currency and weather trends are key external drivers for CPF's exports.

  • China JV losses and future feed costs China's pig joint venture (CTI) lost ~2 billion baht and may take 1–2 years to recover. Also, El Niño is expected to raise feed costs from late 2027, squeezing margins—a real counterweight.

    These are significant negatives that could offset near-term positives.

August 2026
▲3▼1

CPF beats Q2, plans Vietnam IPO, but China JV drags

  • Q2 profit beat CPF beat Q2 profit forecasts by 13–20%, helped by strong exports and Vietnam operations. This shows the core business is performing better than expected, which supports the stock price.

    Earnings beat is a direct positive catalyst for the stock.

  • Vietnam IPO plan CPF plans to list its Vietnam unit (CP Vietnam) via IPO, potentially unlocking value. This could give investors a new way to profit from CPF's growth in Vietnam.

    IPO plan is a new strategic move that may boost shareholder value.

  • Weak baht and El Niño lift exports A weak baht (14-month low) and El Niño-driven meat supply tightening should lift export earnings and prices. Q3 profit is expected to recover, giving a near-term boost.

    Currency and weather trends are key external drivers for CPF's exports.

  • China JV losses and future feed costs China's pig joint venture (CTI) lost ~2 billion baht and may take 1–2 years to recover. Also, El Niño is expected to raise feed costs from late 2027, squeezing margins—a real counterweight.

    These are significant negatives that could offset near-term positives.

Latest
▲3▼1

Weak Baht and El Niño Lift CPF, but Feed Costs Loom

  • Weak baht boosts export earnings The Thai baht fell to a 14-month low and is expected to stay weak after US and Japanese rate hikes widened the interest gap. A weaker baht makes CPF's chicken and shrimp exports cheaper and raises the baht value of foreign sales, directly lifting profit.

    This is a core new force driving CPF's export revenue and was highlighted by multiple brokers.

  • El Niño to tighten meat supply and raise prices Forecasters see a strong El Niño late this year, bringing heat that slows pig and chicken growth and cuts supply. Historically pork prices rise about 17% in such periods, which would boost CPF's meat selling prices and profit.

    This is a new, specific supply-side driver that brokers say will lift meat prices and benefit CPF.

  • Strong export demand and Q3 profit recovery Thailand's August exports jumped 24.3%, with processed chicken up 10.5% and shrimp up 18.8%. Brokers expect CPF's third-quarter profit to grow from a year earlier on rebounding pork and chicken prices and strong chicken exports, supporting the stock.

    This shows real demand for CPF's products and improving earnings, a key reason the stock is moving.

  • Rising feed costs from El Niño El Niño is also expected to push up feed costs, which will start affecting CPF from late 2027. Higher costs for soybean and other feed ingredients would squeeze margins, a real counterweight to the near-term positives.

    This is the main risk that could offset the positive drivers and gives a fair, balanced picture.

▲3▼1

CPF beats profit forecasts, plans Vietnam IPO, but China drags

  • Q2 profit beats expectations CPF's second-quarter core profit of 4.57 billion baht beat market forecasts by 13-20%, helped by strong exports and Vietnam. This reassures investors that the company is more profitable than feared, supporting the share price.

    This is the key new financial result that directly answers why the stock is moving.

  • Vietnam IPO plan and strong Vietnam growth CPF is preparing to list its Vietnam unit (CP Vietnam) on the stock exchange, selling about 10% while keeping control. Vietnam's pig and chicken businesses are growing strongly, and the IPO could unlock value, potentially lifting CPF's share price.

    This is a new, concrete catalyst that could re-rate the stock.

  • China pig business remains a drag CPF's China joint venture (CTI) lost about 2 billion baht in Q2 due to weak pig prices and oversupply. Management says it may take 1-2 years to recover, weighing on overall profit and limiting upside for the stock.

    This is the main counterweight that explains why the stock isn't rising more.

  • Weaker baht and export strength Thailand's exports surged 20.8% in June, with processed chicken highlighted as a winner. A weaker baht makes CPF's exports cheaper and boosts overseas earnings, while recovering meat prices and cost easing are expected to lift second-half profit.

    This macro tailwind supports CPF's export-driven revenue and margin recovery.

Danone SA (BN.PA)

Q3 2026
▲4

Danone buys growth brands, beats Q2, strengthens patent

  • Acquires MADE Group and full Australian dairy JV Danone is buying Australia's MADE Group (high-protein drinks, gut-health yoghurts) and the rest of its Australian dairy joint venture. Both add fast-growing health products and are expected to lift profit margins and earnings per share from the first year, supporting the shares.

    A concrete deal that adds growth and profit, directly supporting the stock.

  • Q2 sales beat forecasts, full-year outlook kept Danone's second-quarter sales grew 4.2% versus the 3.7% expected, with specialized nutrition and water (helped by a heatwave) both strong. First-half operating profit and margin came in slightly ahead, and the company kept its full-year growth target, reassuring investors.

    The quarter's results beat expectations and confirm the company is on track.

  • Completes Huel acquisition, expands functional nutrition Danone finished buying Huel, the meal-shake and nutrition brand, adding its direct-to-consumer reach to Danone's global scale. Huel joins the accounts from September 1, 2026, broadening Danone's functional nutrition business and its growth options.

    A completed deal that expands a fast-growing part of the business.

  • New U.S. patent strengthens Akkermansia gut-health IP Danone's subsidiary won a new U.S. patent and favorable rulings protecting its Akkermansia weight-loss ingredient, though appeals continue. Stronger legal protection supports its launch of Akkermansia products in the U.S., Europe and Asia, a potential new sales driver.

    Protects a promising new product line, a real positive for future sales.

July 2026
▲4

Danone buys growth brands, beats Q2, strengthens patent

  • Acquires MADE Group and full Australian dairy JV Danone is buying Australia's MADE Group (high-protein drinks, gut-health yoghurts) and the rest of its Australian dairy joint venture. Both add fast-growing health products and are expected to lift profit margins and earnings per share from the first year, supporting the shares.

    A concrete deal that adds growth and profit, directly supporting the stock.

  • Q2 sales beat forecasts, full-year outlook kept Danone's second-quarter sales grew 4.2% versus the 3.7% expected, with specialized nutrition and water (helped by a heatwave) both strong. First-half operating profit and margin came in slightly ahead, and the company kept its full-year growth target, reassuring investors.

    The quarter's results beat expectations and confirm the company is on track.

  • Completes Huel acquisition, expands functional nutrition Danone finished buying Huel, the meal-shake and nutrition brand, adding its direct-to-consumer reach to Danone's global scale. Huel joins the accounts from September 1, 2026, broadening Danone's functional nutrition business and its growth options.

    A completed deal that expands a fast-growing part of the business.

  • New U.S. patent strengthens Akkermansia gut-health IP Danone's subsidiary won a new U.S. patent and favorable rulings protecting its Akkermansia weight-loss ingredient, though appeals continue. Stronger legal protection supports its launch of Akkermansia products in the U.S., Europe and Asia, a potential new sales driver.

    Protects a promising new product line, a real positive for future sales.

Latest
▲4

Danone buys growth brands, beats Q2, strengthens patent

  • Acquires MADE Group and full Australian dairy JV Danone is buying Australia's MADE Group (high-protein drinks, gut-health yoghurts) and the rest of its Australian dairy joint venture. Both add fast-growing health products and are expected to lift profit margins and earnings per share from the first year, supporting the shares.

    A concrete deal that adds growth and profit, directly supporting the stock.

  • Q2 sales beat forecasts, full-year outlook kept Danone's second-quarter sales grew 4.2% versus the 3.7% expected, with specialized nutrition and water (helped by a heatwave) both strong. First-half operating profit and margin came in slightly ahead, and the company kept its full-year growth target, reassuring investors.

    The quarter's results beat expectations and confirm the company is on track.

  • Completes Huel acquisition, expands functional nutrition Danone finished buying Huel, the meal-shake and nutrition brand, adding its direct-to-consumer reach to Danone's global scale. Huel joins the accounts from September 1, 2026, broadening Danone's functional nutrition business and its growth options.

    A completed deal that expands a fast-growing part of the business.

  • New U.S. patent strengthens Akkermansia gut-health IP Danone's subsidiary won a new U.S. patent and favorable rulings protecting its Akkermansia weight-loss ingredient, though appeals continue. Stronger legal protection supports its launch of Akkermansia products in the U.S., Europe and Asia, a potential new sales driver.

    Protects a promising new product line, a real positive for future sales.

© 2026 MarketIVWhy